Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of PIM2 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | IP,WB-Ce,IHC-P |
More info about PIM2 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB2305 |
| Product name: | PIM2 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of PIM2. |
| Gene id: | 11040 |
| Gene name: | PIM2 |
| Gene alias: | - |
| Gene description: | pim-2 oncogene |
| Immunogen: | A synthetic peptide (conjugated with KLH) corresponding to C-terminus of human PIM2. |
| Protein accession: | NP_006866;Q9P1W9 |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (1:1000) Immunohistochemistry (1:50-100 Immunoprecipitation) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | Western blot analysis of PIM2 polyclonal antibody (Cat # PAB2305) in HL-60 cell lysate. PIM2 (arrow) was detected using purified polyclonal antibody. Secondary HRP-anti-rabbit was used for signal visualization with chemiluminescence. |
| Applications: | IP,WB-Ce,IHC-P |
| Shipping condition: | Dry Ice |
| Publications: | Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity.Pogacic V, Bullock AN, Fedorov O, Filippakopoulos P, Gasser C, Biondi A, Meyer-Monard S, Knapp S, Schwaller J. Cancer Res. 2007 Jul 15;67(14):6916-24. |